The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review
Open Access
- 18 July 2022
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (7) , 1167
Abstract
Background: Clinician-reported outcome measures (ClinROMs) are frequently used in clinical trials and daily practice to evaluate the disease status and evolution of skin disorders. The minimal important difference (MID) represents the smallest difference that decreases the disease impact enough to make a treatment change worthwhile for patients. As no clear guidance exists on the preferred method to calculate MIDs for ClinROMs, we evaluated how the published values for different skin disorders should be interpreted. Methods: A systematic search was performed for MIDs of ClinROMs that focus on skin disorders and/or symptoms. The results of the questions in the credibility instrument for MIDs of Devji et al., 2020 were analyzed to gain insights into the meaning of these MIDs. Results: 29 MIDs were identified. The most common skin diseases were atopic dermatitis/eczema, followed by bullous disorders and psoriasis. A minimal important difference from the patients’ perspective was determined in 31% of the cases. However, in 41.4% of the cases, it concerned a substantial rather than a minimal difference in disease severity rated by physicians. Over half (55.1%) of the studies contained an inadequate number of patients (n < 150). MID values increased substantially in patients with severe compared to mild disease. Conclusions: MIDs of ClinROMs for skin disorders should be carefully interpreted due to the substantial differences in methodology between the studies. There is an urgent need for a consensus method to report reliable MIDs. Otherwise, this lack of uniformity could not only affect the design and conclusion of clinical trials but also skew treatment decisions.Keywords
Funding Information
- the Scientific Research Foundation-Flanders (18B2721N, 1843719N, 1831512N)
This publication has 32 references indexed in Scilit:
- Severity and functional disability of patients with occupational contact dermatitis: validation of the German version of the Occupational Contact Dermatitis Disease Severity IndexContact Dermatitis, 2014
- Minimal Clinically Important DifferenceJAMA, 2014
- Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatmentBritish Journal of Dermatology, 2014
- Responsiveness to Change and Interpretability of the Simplified Psoriasis IndexJournal of Investigative Dermatology, 2014
- The Localized Scleroderma Cutaneous Assessment Tool: Responsiveness to change in a pediatric clinical populationJournal of the American Academy of Dermatology, 2013
- Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activityQuality of Life Research, 2013
- EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important differenceAllergy, 2011
- A point of minimal important difference (MID): a critique of terminology and methodsExpert Review of Pharmacoeconomics & Outcomes Research, 2011
- Surveying Physicians To Determine the Minimal Important DifferenceJournal of Clinical Epidemiology, 1999
- Measurement of health statusControlled Clinical Trials, 1989